Pregnancy Outcome in Patients With POI – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“In their new systematic review, Julia Deneer, Yvonne Louwers, and Eileen Lashley summarize and evaluate studies primarily investigating pregnancy outcomes in women with idiopathic premature ovarian insufficiency (POI) compared with women without POI, following both spontaneous and assisted conceptions.
Despite screening 3640 articles, none met the predefined inclusion criteria set for the study. Nevertheless, comparison of available data on POI pregnancies with outcomes in the general population suggests an increased risk of early pregnancy loss, after (non-) donor ART.
Given that POI is a complex condition with profound effects on physical and mental health, the authors discuss the importance of further exploration of its potential impact on pregnancy and emphasize the need for well-designed future studies in this field.
Published open access, a pre-proof is available to read in full from our in-press articles section, now.”
Title: Pregnancy outcome in patients with idiopathic premature ovarian insufficiency: a systematic review of the literature
Authors: Julia Deneer, Yvonne Louwers, Eileen Lashley
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment